• 1
    Bisno AL. Group A streptococcal infections and acute rheumatic fever. N Engl J Med 1991; 325: 78393.
  • 2
    Kaplan EL. The resurgence of group A streptococcal infections and their sequelae. Eur J Clin Microbiol Infect Dis 1991; 10: 557.
  • 3
    van Asselt GJ, Mouton RP, van Boven CPA. Penicillin tolerance and treatment failure in group A streptococcal pharyngitis. Eur J Clin Microbiol Infect Dis 1996; 15: 10715.
  • 4
    Brook I. The role of β-lactamase-producing bacteria in the persistence of streptococcal tonsillar infection. Rev Infect Dis 1984; 6: 6017.
  • 5
    Peter G. Streptococcal pharyngitis: current therapy and criteria for evaluation of new agents. Clin Infect Dis 1992; 14(Suppl. 2): S21823.
  • 6
    Moellering RC Jr. Revolutionary changes in the macrolide and azalide antibiotics. Am J Med 1991; 91(Suppl. 1): S14.
  • 7
    Lowbury EJL, Hurst L. The sensitivity of staphylococci and other wound bacteria to erythromycin, oleandomycin and spiramycin. J Clin Pathol 1959; 12: 1639.
  • 8
    Dixon JMS, Lipinski E. Occurrence of antibiotic resistance in hemolytic streptococci. In SchlessingerD, ed. Microbiology — 1982. Washington : American Society for Microbiology, 1982: 147147.
  • 9
    Duval J. Evolution and epidemiology of MLS resistance. J Antimicrob Chemother 1985; 16(Suppl. A): S13749.
  • 10
    Nakae M, Murai T, Kaneko Y, Mitsuhashi S. Drug resistance in Streptococcus pyogenes isolated in Japan (1974–1975). Antimicrob Agents Chemother 1977; 12: 4278.
  • 11
    Miyamoto Y, Takizawa K, Matsushima A, Asai Y, Nakatsuka S. Stepwise acquisition of multiple drug resistance by beta-hemolytic streptococci and difference in resistance pattern by type. Antimicrob Agents Chemother 1978; 13: 399404.
  • 12
    Maruyama S, Yoshioka H, Fujita K, Takimoto M, Satake Y. Sensitivity of group A streptococci to antibiotics. Am J Dis Child 1979; 133: 11435.
  • 13
    Mitsuhashi S, Inoue M, Saito K, Nakae M. Drug resistance in Streptococcus pyogenes strains isolated in Japan. In SchlessingerD, ed. Microbiology — 1982. Washington : American Society for Microbiology, 1982: 151151.
  • 14
    Spencer RC, Wheat PF, Magee JT, Brown EH. Erythromycin resistance in streptococci [letter]. Lancet 1989; i: 168.
  • 15
    Wittler RR, Yamada SM, Bass JW, Hamill R, Wiebe RA, Ascher DP. Penicillin tolerance and erythromycin resistance of group A β-hemolytic streptococci in Hawaii and the Philippines. Am J Dis Child 1990; 144: 5879.
  • 16
    Betriu C, Sanchez A, Gomez M, Cruceyra A, Picazo JJ. Antibiotic susceptibility of group A streptococci: a 6-year follow-up study. Antimicrob Agents Chemother 1993; 37: 171719.
  • 17
    van Asselt GJ, Sloos JH, Mouton RP, van Boven CPA, van de Klundert JAM. Susceptibility of Streptococcus pyogenes to azithromycin, clarithromycin, erythromycin and roxithromycin. J Med Microbiol 1995; 43: 38691.
  • 18
    Zackrisson G, Lindt L, Roos K, Larsson P. Erythromycin-resistant beta-hemolytic streptococci group A in Göteborg, Sweden. Scand J Infect Dis 1988; 20: 41920.
  • 19
    Stingemore N, Francis GR, Toohey M, McGechie B. The emergence of erythromycin resistance in Streptococcus pyogenes in Fremantle, Western Australia. Med J Aust 1989; 150: 62631.
  • 20
    Phillips G, Parratt D, Orange GV, Harper I, McEwan H, Young N. Erythromycin-resistant Streptococcus pyogenes. J Antimicrob Chemother 1990; 25: 7234.
  • 21
    Seppälä H, Nissinen A, Järvinen H, et al. Resistance to erythromycin in group A streptococci. N Engl J Med 1992; 326: 2927.
  • 22
    Hsueh PR, Chen HM, Huang AH, Wu JJ. Erythromycin-resistant Streptococcus pyogenes in Taiwan [abstract E54]. In: Program and Abstracts of the 35th International Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA. Washington , DC : American Society for Microbiology, 1995: 95.
  • 23
    Cornaglia G, Lissandrini D, Valentini M, Fontana R. Inusuale incidenza di resistenza ai macrolidi in isolati clinici di Streptococcus pyogenes [abstract]. In: Programma e riassunti del 25 Congresso Nazionale della Società Italiana di Microbiologia, Alghero, Italy . SIM, 1995: 337.
  • 24
    Cipriani P, Debbia EA, Gesu GP, et al. Indagine policentrica AMCLI sull'incidenza di resistenze agli antibiotici in S. pyogenes [abstract G122]. In: Programma e riassunti del XXIV Congresso Nazionale dell'Associazione Italiana Microbiologi Clinici, Riva del Garda, Italy . AMCLI, 1995: 182.
  • 25
    Tempera G, Furneri PM, Nicolosi VM, Nicoletti G. In vitro activity of some macrolides against S. pyogenes [abstract 3.12]. In: Program and Abstracts of the 3rd International Conference on the Macrolides, Azalides and Streptogramins, Lisbon, Portugal. 1996: 30.
  • 26
    National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 3rd edn. Approved standard M7-A3. Villanova , PA : NCCLS, 1993.
  • 27
    National Committee for Clinical Laboratory Standards. Performance standard for antimicrobial susceptibility testing. Sixth informational supplement M100-S6. Villanova , PA : NCCLS, 1995.